Intercept Announces Updated U.S. Prescribing Information for Ocaliva, Says Hepactic Decompensation And Failure Have Been Reported In Patients With Advanced Cirrhosis When Ocaliva Was Dosed More Frequently Than Recommended Starting Dosage